Opportunity Alert: Stocks from India's Emerging Businesses
Here is the latest financial fact sheet of BALAXI PHARMA. For more details, see the BALAXI PHARMA quarterly results and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -7.4 |
No. of shares | m | 10.23 |
1 Week | % | -13.1 |
1 Month | % | 4.2 |
1 Year | % | 34.2 |
52 week H/L | Rs | 706.0/303.6 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
BALAXI PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | 702 | |
Low | Rs | NA | NA | NA | NA | 342 | |
Sales per share (Unadj.) | Rs | 0 | 44.7 | 45.6 | 231.3 | 279.4 | |
Earnings per share (Unadj.) | Rs | -2.5 | 6.5 | 6.1 | 38.1 | 47.7 | |
Diluted earnings per share | Rs | -0.8 | 1.9 | 6.0 | 37.3 | 46.6 | |
Cash flow per share (Unadj.) | Rs | -2.5 | 6.5 | 6.1 | 38.4 | 48.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.50 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.49 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0.1 | |
Book value per share (Unadj.) | Rs | 5.1 | 11.6 | 27.7 | 65.0 | 113.2 | |
Adj. book value per share | Rs | 1.5 | 3.4 | 27.1 | 63.5 | 110.6 | |
Shares outstanding (eoy) | m | 3.04 | 3.04 | 10.00 | 10.00 | 10.00 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 1.9 | |
Avg P/E ratio | x | 0 | 0 | 0 | 0 | 10.9 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | 10.8 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | 4.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 1.0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | 5,218 | |
Total wages/salary | Rs m | 2 | 9 | 21 | 85 | 125 |
BALAXI PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 136 | 456 | 2,313 | 2,794 | |
Other income | Rs m | 0 | 9 | 6 | 22 | 50 | |
Total revenues | Rs m | 0 | 145 | 462 | 2,336 | 2,844 | |
Gross profit | Rs m | -8 | 16 | 83 | 427 | 508 | |
Depreciation | Rs m | 0 | 0 | 0 | 3 | 5 | |
Interest | Rs m | 0 | 0 | 0 | 3 | 8 | |
Profit before tax | Rs m | -8 | 24 | 88 | 443 | 545 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 5 | 27 | 62 | 69 | |
Profit after tax | Rs m | -8 | 20 | 61 | 381 | 477 | |
Gross profit margin | % | 0 | 11.5 | 18.1 | 18.4 | 18.2 | |
Effective tax rate | % | 0 | 19.4 | 30.6 | 14.0 | 12.6 | |
Net profit margin | % | 0 | 14.5 | 13.4 | 16.5 | 17.1 |
BALAXI PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 16 | 58 | 349 | 938 | 1,410 | |
Current liabilities | Rs m | 1 | 26 | 82 | 347 | 633 | |
Net working cap to sales | % | 0 | 23.5 | 58.4 | 25.5 | 27.8 | |
Current ratio | x | 12.5 | 2.2 | 4.2 | 2.7 | 2.2 | |
Inventory Days | Days | 0 | 9 | 7 | 5 | 8 | |
Debtors Days | Days | 0 | 146,964 | 2,377 | 1,211 | 374 | |
Net fixed assets | Rs m | 0 | 3 | 11 | 59 | 355 | |
Share capital | Rs m | 30 | 30 | 100 | 100 | 100 | |
"Free" reserves | Rs m | -15 | 5 | 177 | 550 | 1,032 | |
Net worth | Rs m | 16 | 35 | 277 | 650 | 1,132 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 17 | 61 | 360 | 997 | 1,765 | |
Interest coverage | x | 0 | 1,221.0 | 184.2 | 160.5 | 72.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0 | 2.2 | 1.3 | 2.3 | 1.6 | |
Return on assets | % | -45.6 | 32.2 | 17.1 | 38.5 | 27.4 | |
Return on equity | % | -49.5 | 55.8 | 22.0 | 58.7 | 42.1 | |
Return on capital | % | -49.5 | 69.3 | 31.9 | 68.6 | 48.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 136 | 456 | 869 | 1,000 | |
Fx outflow | Rs m | 0 | 0 | 10 | 110 | 87 | |
Net fx | Rs m | 0 | 136 | 447 | 759 | 913 |
BALAXI PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -7 | -15 | -140 | 0 | 341 | |
From Investments | Rs m | -0 | -0 | -2 | -60 | -284 | |
From Financial Activity | Rs m | 0 | 0 | 181 | 36 | -2 | |
Net Cashflow | Rs m | -7 | -15 | 39 | -23 | 55 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Ashish Maheshwari | COMP SEC: Nidhin Jose | YEAR OF INC: 1942 | NSE CODE: 911309 | FV (Rs): 10 | DIV YIELD (%): 0.1 |
More Trading Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
Compare BALAXI PHARMA With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
After opening the day higher, Indian share markets continued their momentum as session progressed and ended higher for the fourth straight session.